Prescribing Practices and Management of Chronic Pain and Substance Use Disorder

Prescribing Practices and Management of Chronic Pain and Substance Use Disorder Course Overview:

This course on prescribing practices and management of chronic pain and substance use disorder is an intensive 2 ½  day course designed for physicians, dentists, nurse practitioners, physician assistants, and other clinicians in all specialties, who need or wish to increase their knowledge and ability to effectively prescribe and control medications while reducing the risk for abuse.  This course is approved by the California Medical Board as meeting the coursework requirements of physician probation.

Research indicates that up to one third of the disciplinary actions taken by Medical Boards are related to physician misprescribing practices.  Learn proper prescribing practices and how best to document prescriptions for controlled substances.  Learn to avoid common pitfalls including: inappropriate dispensing of medications from physician’s offices, prescribing large amounts of narcotics at frequent intervals, or prescribing to family members, friends, or a person with a known history of substance abuse.

This course has been developed to enhance the physician’s ability to effectively prescribe controlled medications, while minimizing their misuse whenever possible.

Course Agenda PDF Register for Prescribing Practices Why you should take Prescribing Practices

21 CME Hours – 2 ½ day program

Scheduled dates:

  • January 17-19, 2019; and
  • June 6-8, 2019.

Daily times:

Day 1 & Day 2:  8:00 AM – 6 PM.

Day 3: 9:00 AM – 12:30 PM.

Program Content:

  1. Proper indications for prescribing.
  2. Choosing the medication.
  3. Requirement of adequate prior examination.
  4. Identifying contra-indications before prescribing.
  5. Identifying potential medication interactions before prescribing.
  6. Non-prescription (over-the-counter) drugs and nutritional supplements.
  7. Herbal remedy interactions.
  8. Food interactions.
  9. Alcohol interactions.
  10. Pharmacokinetics.
  11. Pharmacodynamics.
  12. Dosing errors.
  13. Informed consent for medications.
  14. Instructions to patients on medications.
  15. Medication warnings for patients.
  16. Safe patient monitoring, and recognizing adverse reactions and therapeutic failure.
  17. Preventing, identifying and managing medication non-compliance.
  18. Collaborative (split) treatment.
  19. Terminating care of a patient on medication.
  20. Controlled substances prescribing requirements.
  21. Treating addicted patients.
  22. Drug-seeking patients.
  23. Substance-abusing patients.
  24. Fraudulent prescriptions.
  25. Prescribing excessive quantities of medications.
  26. Clinician storage and dispensing of controlled substances.
  27. Chronic pain diagnosis.
  28. Chronic pain medication treatment.
  29. Classes of medications associated with increased risk.
  30. Medications prescribed for psychoactive effects.
  31. Prescribing function-enhancing medications.
  32. Internet medication prescribing.
  33. Internet medication purchases by patients.
  34. Aiding and abetting of unlicensed practice.
  35. Prescribing by supervised nurse practitioners, naturopaths and physician assistants.
  36. Formulary conflicts.
  37. Acceptable off-label medication prescribing.
  38. Deviations from pharmaceutical manufacturers’ recommendations.
  39. Sources of information for prescribing medications.
  40. Illegible, ambiguous and contradictory medication orders.
  41. Verbal orders, standing orders, PRN orders.
  42. Self-prescribing by clinicians.
  43. Prescribing for family members or friends.
  44. Common bases for actions by regulatory agencies relating to medications.


Courses are held in the San Francisco Bay Area, typically nearby the San Francisco International Airport or within downtown San Francisco, depending on the number of registrants.  Call for details and for help booking nearby hotels.


$1,749. Organizations sponsoring multiple registrants should call (650) 212-4904 to discuss reduced tuition fees that may apply.

Register for Prescribing Practices

CME Accreditation:


At the conclusion of the course, attendees should be able to:

1.   Identify and prevent the common causes of prescribing-related patient injury.

2.   Integrate satisfaction of patients and families with medication treatment.

3.   Recognize and protect patients’ legal rights such as informed consent relating to medications.

4.   Recognize and comply with clinicians’ legal responsibilities relating to medications.

5.   Integrate supervision by physicians of mid-level practitioners who prescribe or monitor medication therapy.

6.   Illustrate cooperation among members of the health care team relating to medications.

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American College of Legal Medicine and the Western Institute of Legal Medicine. The American College of Legal Medicine is accredited by the ACCME to sponsor continuing medical education for physicians.

The American College of Legal Medicine designates this live and enduring materials activity for a maximum of 21.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The American College of Legal Medicine, Continuing Medical Education Department has reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable.

General Disclaimer

The statements and opinions contained in this program are solely those of the individual authors and contributors and not of the WILM Programs. The appearance of the advertisements is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The content of this presentation and publication may contain discussion of off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses. The WILM Programs disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the presentation or advertisements.